Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 2007 Aug 14;69(7):631-9. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This study is important for providing data and insight on strategies for attempting to detect latent or prodromal AD at the pre-MCI stage. This approach could be incorporated into early detection methods that will be increasingly relevant once effective preventive interventions are available.

    View all comments by John Trojanowski

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
  2. Still Early Days for α-synuclein Fluid Marker
  3. In Healthy Brains, Does Aβ Really Matter?
  4. Keystone: Pulse-Chasing AD Biomarkers, Snaring γ-Secretase Targets
  5. More ADNI Results 2: It’s All About Power
  6. Enabling Technologies for Alzheimer Disease Research: Seventh Bar Harbor Workshop, 2007, Part 2
  7. Speed of Biomarker Changes Herald Alzheimer’s Disease

Research Timeline Event

  1. CSF Aβ/tau signature identifies prodromal AD within MCI cohorts, predicts cognitive decline